2020
DOI: 10.1111/cbdd.13674
|View full text |Cite
|
Sign up to set email alerts
|

Spectrum of deep learning algorithms in drug discovery

Abstract: Deep learning (DL) algorithms are a subset of machine learning algorithms with the aim of modeling complex mapping between a set of elements and their classes. In parallel to the advance in revealing the molecular bases of diseases, a notable innovation has been undertaken to apply DL in data/libraries management, reaction optimizations, differentiating uncertainties, molecule constructions, creating metrics from qualitative results, and prediction of structures or interactions. From source identification to l… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 133 publications
0
6
0
Order By: Relevance
“…Besides generating new chemical structures with favorable pharmacokinetics, ML methods are also used in pharmaceutical research and development for peptide design, compound activity prediction and for assisting scoring protein–ligand interaction (docking). , An example of the latter was proposed by Batra et al for efficiently identifying ligands that can potentially limit the host–virus interactions of SARS-CoV-2. Those authors designed a high-throughput strategy based on CompChem+ML that involved high-fidelity docking studies to find candidates displaying high-binding affinities.…”
Section: Selected Applications and Paths Toward Insightsmentioning
confidence: 99%
“…Besides generating new chemical structures with favorable pharmacokinetics, ML methods are also used in pharmaceutical research and development for peptide design, compound activity prediction and for assisting scoring protein–ligand interaction (docking). , An example of the latter was proposed by Batra et al for efficiently identifying ligands that can potentially limit the host–virus interactions of SARS-CoV-2. Those authors designed a high-throughput strategy based on CompChem+ML that involved high-fidelity docking studies to find candidates displaying high-binding affinities.…”
Section: Selected Applications and Paths Toward Insightsmentioning
confidence: 99%
“…While ML algorithms like SVM have shown a high ratio of predicted known hits and lower false-positive rates, DL algorithms can improve prediction due to their dependable classification capabilities, robust feature extraction ability, and low generalization error. LigBuilder, ADAPT, PEP, SYNOPSIS, GANDI, and MEGA are among the de novo drug design tools that use the structure-based drug design technique (Piroozmand et al, 2020). ADMET prediction using deep learning methods has been demonstrated to be more accurate than predictions using classical ML approaches such as random forest algorithms.…”
Section: In Early Stages Of Drug Discoverymentioning
confidence: 99%
“…Besides generating new chemical structures with favorable pharmacokinetics, ML methods are also used in pharmaceutical research and development for peptide design, compound activity prediction and for assisting scoring protein-ligand interaction (docking). 696,[702][703][704] An example of the latter was proposed by Batra et al 705 for efficiently identifying ligands that can potentially limit the host-virus interactions of SARS-CoV-2. Those authors designed a high-throughput strategy based on CompChem+ML that involved high-fidelity docking studies to find candidates displaying high-binding affinities.…”
Section: Drug Designmentioning
confidence: 99%